Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5691049 | Contraception | 2016 | 10 Pages |
Abstract
Limited evidence showing increased risk of ovulation and breakthrough bleeding raises concern for decreased contraceptive efficacy when COCs are co-administered with SJW. The pharmacokinetic evidence is mixed but suggests that SJW administration may be associated with weak to moderate induction of the metabolism of COCs.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Erin N. Berry-Bibee, Myong-Jin Kim, Naomi K. Tepper, Halley E.M. Riley, Kathryn M. Curtis,